Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Arturo Cortes-Telles (Merida, Yucatan, Mexico), Arturo Cortes-Telles, Angel Emmanuel Vega-Sanchez, Jose Luis Che-Morales, Danielle Aimee Manjarrez-Martin, Gary Kosai Vargas-Mendoza. Serum procalcitonin as a potential biomarker of surgery in parapneumonic pleural effusions. Eur Respir J 2016; 48: Suppl. 60, 603

Member's Comments

No comment yet.

Related content which might interest you: Serum albumin and probability of pleural effusion in patients with community-acquired pneumonia Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions? Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Protein profiling of pleural fluid in guiding management of infectious parapneumonic effusion in children Source: International Congress 2015 – Paediatric pulmonary infections Year: 2015 Pleural fluid procalcitonin levels in identifying pleural effusions due to infection Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009 Infectious pleural effusions Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=204 Year: 2002 Predictive factors, microbiology and outcome of patients with parapneumonic effusion Source: Eur Respir J 2011; 38: 1173-1179 Year: 2011 Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions? Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Decreasing incidence of parapneumonic pleural effusions (PPE) in children Source: International Congress 2016 – Paediatric respiratory infections Year: 2016 Role of markers C-Reactive Protein, Procalcitonin and TREM-1 in diagnosis of infection pleural effusion Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Serum C-reactive protein levels predict the need for surgical intervention in patients with empyema/complicated parapneumonic pleural effusions Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 Pleural fluid C-reactive protein concentration in discriminating uncomplicated from complicated parapneumonic pleural effusion Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Intrapleural tenectaplase therapy in treatment of loculated parapneumonic pleural effusions and empyema Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Procalcitonin and CRP levels in pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Pleural fluid IL-6 levels in the identification of the complicated parapneumonic pleural effusion Source: Annual Congress 2008 - Pleural effusion Year: 2008 Risk factors associated to surgical treatment of parapneumonic effusion and empyema Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Human beta defensin-2 serum levels are lower in complicated infectious pleural effusions Source: Annual Congress 2013 –Interesting research questions Year: 2013 Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021